Programme
The educational programme features sessions presented by each global society.
Please note all programme times are Greenwich Mean Time (GMT)
| TIME | PROGRAMME |
|---|---|
| 08.00 – 08.05 | WELCOME Robin Gore |
| 08.05 – 09.05 |  Japanese Society of Allergology |
| 08.05 – 08.20 | Allergen immunotherapy in asthma Kazuyuki Nakagome |
| 08.20 – 08.35 | Advances in the diagnosis and treatment of Stevens–Johnson syndrome/toxic epidermal necrolysis Yuko Watanabe |
| 08.35 – 08.50 | Japanese guidelines for atopic dermatitis Hidehisa Saeki |
| 08.50 – 09.05 | Panel Q&A |
| 09:05 – 09:20 | BREAK |
| 09.20 – 10.20 | COMPANY SYMPOSIUM Thermo Fisher Scientific |
| 10.20 – 11.20 |  Chaired by: Claudia Gore |
| 10.20 – 10.35 | Lessons learned on the standardisation of oral food challenges Philippe Eigenmann |
| 10.35 – 10.50 | EAACI’s Strategic Vision: Artificial Intelligence as a Transformative Force in Allergic Disease Management – Clinical Applications and Mechanistic Insights Mo Shamji |
| 10.50 – 11.05 | EAACI strategy for the precise management of antibiotic allergy and its impact on EU antibiotic resistance Maria Torres |
| 11.05 – 11.20 | Panel Q&A |
| 11.20 – 11.40 | BREAK |
| 11.40 – 13.00 | Presidents’ Forum Live meeting of the Presidents of the Partner Societies Chaired by: Speakers: For BSACI: Dr Robin Gore For EAACI: Professor Maria Torres For WAO: Professor Mario Morais Almeida For AAAAI: Dr Frank S. Virant For JSA: Dr Motohiro Ebisawa |
| 13.00 – 13.40 | BREAK |
| 13.40 – 14.40 | Company symposium |
| 14.40 – 15.40 |  Chaired by: Stephen Durham |
| 14.40 – 14.55 | Allergy Psychology interactive cases Christina Jones |
| 14.55 – 15.10 | Eczema interactive cases Carsten Flohr |
| 15.10 – 15.25 | Venom allergy interactive cases Pamela Ewan |
| 15.25 – 15.40 | Panel Q&A |
| 15.40 – 15.55 | BREAK |
| 15.55 – 16.55 |  Chaired by: Shuaib Nasser |
| 15.55 – 16.10 | Food Protein-Induced Enterocolitis Syndrome (FPIES): Current Status and Future Directions Carina Venter |
| 16.10 – 16.25 | Pollen-Food Allergy Syndrome: Consensus on Management Amanda Cox |
| 16.25 – 16.40 | Omalizumab Treatment of Food Allergy Aikaterini Anagnostou |
| 16.40 – 16.55 | Panel Q&A |
| 16.55 – 17.10 | BREAK |
| 17.10 – 18.10 |  Chaired by: Olympia Tsilochristou |
| 17.10 – 17.25 | DRESS syndrome: A literature review and treatment algorithm Luz Fonacier |
| 17.25 – 17.40 | DRACMA’ guideline update 2024 – Milk supplement/replacement formulas for infants and toddlers with CMA Alessandro Fiocchi |
| 17.40 – 17.55 | Standards for intravenous Rapid Drug Desensitisation Ricardo Madrigal |
| 17.55 – 18.10 | Panel Q&A |
| 18.10 – 18.15 | CLOSING AND PRESIDENT’S REMARKS |
Accreditation and Designation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of AAAAI and the British Society for Allergy & Clinical Immunology (BSACI). The AAAAI is accredited by the ACCME to provide continuing medical education for physicians.
The American Academy of Allergy, Asthma & Immunology designates this live activity for a maximum of a Pending final approval, up to 5 AMA PRA Category 5 Credits™ will be available. Physicians should claim only the credit commensurate with the extent of their participation in the activity.